A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles.

Out, H J; David, I; Ron-El, R; Friedler, S; Shalev, E; Geslevich, J; Dor, J; Shulman, A; Ben-Rafael, Z; Fisch, B; Dirnfeld, M

Out, H J; David, I; Ron-El, R; Friedler, S; Shalev, E; Geslevich, J; Dor, J; Shulman, A; Ben-Rafael, Z; Fisch, B; Dirnfeld, M.

Affiliation

Out HJ; Organon Laboratories, Cambridge Science Park, Cambridge, UK. h.out@organon.cge.akzonobel.nl

Hum Reprod ; 16(6): 1104-9, 2001 Jun.

Article in En | MEDLINE | ID: mdl-11387277

Subject(s)

Follicle Stimulating Hormone/administration & dosage; Sperm Injections, Intracytoplasmic; Adult; Chorionic Gonadotropin/administration & dosage; Double-Blind Method; Embryo Transfer; Female; Follicle Stimulating Hormone/adverse effects; Follicle Stimulating Hormone/blood; Humans; Luteinizing Hormone/blood; Ovarian Hyperstimulation Syndrome/chemically induced; Ovulation Induction; Pregnancy; Prospective Studies; Recombinant Proteins/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sperm Injections, Intracytoplasmic / Follicle Stimulating Hormone Type of study: Clinical_trials / Observational_studies Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Hum Reprod Journal subject: MEDICINA REPRODUTIVA Year: 2001 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links